Odyssey Health, Inc. (ODYY): debt financing — Odyssey Health extends maturity of officer/director promissory notes to Jan 31, 2024; conversion at $0.12/share

Odyssey Health, Inc.

Extended maturity of $25,000 promissory notes from two officers and two directors to January 31, 2024.
Conversion price remains at $0.12 per share; notes convertible prior to maturity.
All other terms of the original December 2021 notes unchanged.
This is the seventh amendment to the notes, previously amended multiple times in 2022 and 2023.

item 1.01 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Odyssey Health, Inc. amended loan with two directors and two officers of the Company maturing January 31, 2024.

Instrument: loan
Counterparty: two directors and two officers of the Company
Maturity: January 31, 2024
Event: amendment

Exact text from the filing

On November 1, 2023, Odyssey Health, Inc., formerly known as Odyssey Group International, Inc. (the “Company”), entered into four Promissory Note Amendments (the “Amendments”), to the Promissory Notes entered into December 21, 2021 and December 22, 2021 and as amended April 20, 2022, June 3, 2022, September 30, 2022, December 30, 2022, March 31, 2023 and June 30, 2023, with two directors and two officers of the Company. Pursuant to the Amendments, the parties have agreed to extend the maturity date of the note to January 31, 2024.

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Odyssey Health, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-007598

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.